Analyst Research

Report Title Price
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Glaxosmithkline Plc Collaborates with KineMed Inc in Biomarker Research Program


Monday, 18 Jun 2012 05:24pm EDT 

KineMed Inc announced that it is to take part in a multiannual research and development program with Glaxosmithkline Plc which will use KineMed Inc's platform to discover biomarkers in therapeutic areas which are of interest to Glaxosmithkline Plc. The program aims to identify, optimize and validate new biomarkers which will allow decisions to be taken more quickly and with greater clarity during clinical trials of compounds used to treat muscular atrophy, fibrosis and metabolic illnesses. 

Company Quote

52.51
-0.31 -0.59%
17 Apr 2014